Order Article Reprints

Kaur I, Tieu T, Deepagan VG, Ali MA, Alsunaydih F, Rudd D, Moghaddam MA, Bourgeois L, Adams TE, Thurecht KJ, et al. Combination of Chemotherapy and Mild Hyperthermia Using Targeted Nanoparticles: A Potential Treatment Modality for Breast Cancer. Pharmaceutics. 2023; 15(5):1389. https://doi.org/10.3390/pharmaceutics15051389

Kaur, Ishdeep, Terence Tieu, Veerasikku G. Deepagan, Muhammad A. Ali, Fahad Alsunaydih, David Rudd, Maliheh A. Moghaddam, Laure Bourgeois, Timothy E. Adams, Kristofer J. Thurecht, and et al. 2023. "Combination of Chemotherapy and Mild Hyperthermia Using Targeted Nanoparticles: A Potential Treatment Modality for Breast Cancer" Pharmaceutics 15, no. 5: 1389. https://doi.org/10.3390/pharmaceutics15051389

Kaur, I., Tieu, T., Deepagan, V. G., Ali, M. A., Alsunaydih, F., Rudd, D., Moghaddam, M. A., Bourgeois, L., Adams, T. E., Thurecht, K. J., Yuce, M., Cifuentes-Rius, A., & Voelcker, N. H. (2023). Combination of Chemotherapy and Mild Hyperthermia Using Targeted Nanoparticles: A Potential Treatment Modality for Breast Cancer. Pharmaceutics, 15(5), 1389. https://doi.org/10.3390/pharmaceutics15051389